The European co-funded project HeaRT aims to develop vocational training on health reporting for journalists.
HeaRT is a 2-year Leonardo da Vinci, Grundvig and Dissemination project co-funded by the Education, Audiovisual and Culture Executive Agency. The project was officially launched
in November 2010.
HeaRT will identify health journalism education opportunities around Europe and review existing literature and knowledge, as well as conduct original research among journalists.
HeaRT is a 2-year Leonardo da Vinci, Grundvig and Dissemination project co-funded by the Education, Audiovisual and Culture Executive Agency. The project was officially launched
in November 2010.
HeaRT will identify health journalism education opportunities around Europe and review existing literature and knowledge, as well as conduct original research among journalists.
LATEST NEWS
30/3-1/4/2012
4th partners meeting in Bucharest >>>
19-20/11/20113rd partners meeting in Madrid >>>
19/08/2011EU Health Journalists' survey >>>
LATEST NEWSLETTER
The project's final outcomes include:
✓ Electronic platform with all available educational courses on health journalism in Europe (with links and useful information on each course)
✓ Training methodology, curriculum and materials that combine expertise from both health and journalism
✓ Seminars for journalists in the 7 EU partner countries
✓ Online training tool on health reporting
✓ European conference in Greece
✓ National info days in United Kingdom, Estonia, Portugal, Romania, Germany and Finland
✓ Electronic platform with all available educational courses on health journalism in Europe (with links and useful information on each course)
✓ Training methodology, curriculum and materials that combine expertise from both health and journalism
✓ Seminars for journalists in the 7 EU partner countries
✓ Online training tool on health reporting
✓ European conference in Greece
✓ National info days in United Kingdom, Estonia, Portugal, Romania, Germany and Finland
The project is kindly supported for its realization in Greece by Pfizer.
This project has been funded with support from the European Commission. This publication [communication] reflects the views only of the author,
and the Commission cannot be held responsible for any use which may be made of the information contained therein.
and the Commission cannot be held responsible for any use which may be made of the information contained therein.
